PTK2 and melanoma: In a previous report, we solved the X-ray co-crystal structure of the inhibitor with the FAK FAT domain, demonstrated its mechanism-of-action through delocalization of FAK from focal adhesions, and showed its anti-cancer effects on tumor cell survival and invasion using in vitro and in vivo model systems of melanoma [5].